Unnatural Amino Acid‐Based Ionic Liquid Enables Oral Treatment of Nonsense Mutation Disease in Mice

Abstract This investigation addresses the challenge of suboptimal unnatural amino acid (UAA) utilization in the site‐specific suppression of nonsense mutations through genetic code expansion, which is crucial for protein restoration and precise property tailoring. A facile and economical oral liquid...

Full description

Bibliographic Details
Main Authors: Yujie Shi, Ningning Shi, Yuelin Yang, Zhetao Zheng, Qing Xia
Format: Article
Language:English
Published: Wiley 2024-04-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202306792
_version_ 1797227502070923264
author Yujie Shi
Ningning Shi
Yuelin Yang
Zhetao Zheng
Qing Xia
author_facet Yujie Shi
Ningning Shi
Yuelin Yang
Zhetao Zheng
Qing Xia
author_sort Yujie Shi
collection DOAJ
description Abstract This investigation addresses the challenge of suboptimal unnatural amino acid (UAA) utilization in the site‐specific suppression of nonsense mutations through genetic code expansion, which is crucial for protein restoration and precise property tailoring. A facile and economical oral liquid formulation is developed by converting UAAs into ionic liquids, significantly enhancing their bioavailability and tissue accumulation. Empirical data reveal a 10‐fold increase in bioavailability and up to a 13‐fold rise in focal tissue accumulation, alongside marked improvements in UAA incorporation efficiency. A 4‐week oral administration in mdx mice, a model for Duchenne muscular dystrophy (DMD), demonstrates the formulation's unprecedented therapeutic potential, with up to 40% dystrophin expression restoration and 75% recovery of normal fiber functions, surpassing existing treatments and exhibiting substantial long‐term safety. This study presents a potent oral dosage form that dramatically improves UAA incorporation into target proteins in vivo, offering a significant advance in the treatment of nonsense mutation‐mediated disorders and holding considerable promise for clinical translation.
first_indexed 2024-04-24T14:41:49Z
format Article
id doaj.art-90abd7c242664e328fc9fb7dc8e338e0
institution Directory Open Access Journal
issn 2198-3844
language English
last_indexed 2024-04-24T14:41:49Z
publishDate 2024-04-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj.art-90abd7c242664e328fc9fb7dc8e338e02024-04-02T20:51:56ZengWileyAdvanced Science2198-38442024-04-011113n/an/a10.1002/advs.202306792Unnatural Amino Acid‐Based Ionic Liquid Enables Oral Treatment of Nonsense Mutation Disease in MiceYujie Shi0Ningning Shi1Yuelin Yang2Zhetao Zheng3Qing Xia4State Key Laboratory of Natural and Biomimetic Drugs Peking University Beijing 100191 ChinaState Key Laboratory of Natural and Biomimetic Drugs Peking University Beijing 100191 ChinaState Key Laboratory of Natural and Biomimetic Drugs Peking University Beijing 100191 ChinaState Key Laboratory of Natural and Biomimetic Drugs Peking University Beijing 100191 ChinaState Key Laboratory of Natural and Biomimetic Drugs Peking University Beijing 100191 ChinaAbstract This investigation addresses the challenge of suboptimal unnatural amino acid (UAA) utilization in the site‐specific suppression of nonsense mutations through genetic code expansion, which is crucial for protein restoration and precise property tailoring. A facile and economical oral liquid formulation is developed by converting UAAs into ionic liquids, significantly enhancing their bioavailability and tissue accumulation. Empirical data reveal a 10‐fold increase in bioavailability and up to a 13‐fold rise in focal tissue accumulation, alongside marked improvements in UAA incorporation efficiency. A 4‐week oral administration in mdx mice, a model for Duchenne muscular dystrophy (DMD), demonstrates the formulation's unprecedented therapeutic potential, with up to 40% dystrophin expression restoration and 75% recovery of normal fiber functions, surpassing existing treatments and exhibiting substantial long‐term safety. This study presents a potent oral dosage form that dramatically improves UAA incorporation into target proteins in vivo, offering a significant advance in the treatment of nonsense mutation‐mediated disorders and holding considerable promise for clinical translation.https://doi.org/10.1002/advs.202306792ionic liquidDMDdystrophin restorationoral treatmentunnatural amino acid
spellingShingle Yujie Shi
Ningning Shi
Yuelin Yang
Zhetao Zheng
Qing Xia
Unnatural Amino Acid‐Based Ionic Liquid Enables Oral Treatment of Nonsense Mutation Disease in Mice
Advanced Science
ionic liquid
DMD
dystrophin restoration
oral treatment
unnatural amino acid
title Unnatural Amino Acid‐Based Ionic Liquid Enables Oral Treatment of Nonsense Mutation Disease in Mice
title_full Unnatural Amino Acid‐Based Ionic Liquid Enables Oral Treatment of Nonsense Mutation Disease in Mice
title_fullStr Unnatural Amino Acid‐Based Ionic Liquid Enables Oral Treatment of Nonsense Mutation Disease in Mice
title_full_unstemmed Unnatural Amino Acid‐Based Ionic Liquid Enables Oral Treatment of Nonsense Mutation Disease in Mice
title_short Unnatural Amino Acid‐Based Ionic Liquid Enables Oral Treatment of Nonsense Mutation Disease in Mice
title_sort unnatural amino acid based ionic liquid enables oral treatment of nonsense mutation disease in mice
topic ionic liquid
DMD
dystrophin restoration
oral treatment
unnatural amino acid
url https://doi.org/10.1002/advs.202306792
work_keys_str_mv AT yujieshi unnaturalaminoacidbasedionicliquidenablesoraltreatmentofnonsensemutationdiseaseinmice
AT ningningshi unnaturalaminoacidbasedionicliquidenablesoraltreatmentofnonsensemutationdiseaseinmice
AT yuelinyang unnaturalaminoacidbasedionicliquidenablesoraltreatmentofnonsensemutationdiseaseinmice
AT zhetaozheng unnaturalaminoacidbasedionicliquidenablesoraltreatmentofnonsensemutationdiseaseinmice
AT qingxia unnaturalaminoacidbasedionicliquidenablesoraltreatmentofnonsensemutationdiseaseinmice